article thumbnail

#ScienceSaturday: March 2, 2024

KIF1A

Wendy Chung discusses advances from the Simons Foundation Powering Autism Research for Knowledge (SPARK) Project, which enrolled 275,000 participants with and without autism, between 2016 and 2022. This has created a platform to learn about autism-associated genes, identify risk factors for subgroups, and better inform new interventions.

article thumbnail

New molecular insights on medical cannabis

Drug Target Review

2016 Jun 23;59(12):5604–21. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. The Journal of Cell Biology. 2016 Sep;7(1):11248. Frontiers in Medicine. 2018 Jun 13;5. Castagna D, Budd DC, Macdonald SJF, et al. J Med Chem. 2012 Feb 1;40(1):31–6.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Building better brain models for Parkinson’s disease and beyond

Drug Target Review

Turning this tide, Professor Jens Christian Schwamborn, a cell biology expert at the University of Luxembourg and co-founder of OrganoTherapeutics , is leading a groundbreaking effort to transform our understanding and treatment of these debilitating diseases.

Disease 52
article thumbnail

Guest Blog: Reflecting on the 2024 Society of Toxicology of Canada Symposium, by Ria Falvo, Director, Reporting

Alta Sciences

Before joining Altasciences, Ria received a Bachelor of Science from McGill Universitys Department of Anatomy and Cell Biology in 1998, and became a Diplomate of the American Board of Toxicology in October 2016.

article thumbnail

Cancer immunotherapy: GDF-15’s role in Anti-PD-1 resistance

Drug Target Review

Coordinated integrin activation by actin-dependent force during T-cell migration. 2016 Oct 10;7(1):13119. LFA-1 in T cell migration and differentiation. Shear forces induce ICAM-1 nanoclustering on endothelial cells that impact on T-cell migration. Current Opinion in Cell Biology. Walling BL, Kim M.

article thumbnail

AM-Pharma Appoints Chief Medical Officer and VP Manufacturing to Support Global Pivotal Trial in Sepsis-associated Acute Kidney Injury

The Pharma Data

USA) from the period of 2006 to 2016. in Cell Biology from Utrecht University. Prior to Aduro, Dr. van de Laar held various development and manufacturing positions at MSD (trademark of Merck & Co., Kenilworth, N.J., Dr. van de Laar holds a M.Sc. in Bioprocess Technology from Wageningen University and a Ph.D. About AM-Pharma.

Trials 40
article thumbnail

Women in Stem with Vicky Marsh Durban

Drug Target Review

I don’t think that it’s harder for women to enter careers in STEM, at least not in the scientific field—cell biology—that I have predominantly worked in. She returned to Cardiff in 2014 for a Research Fellowship at the European Cancer Stem Cell Research Institute.

Doctors 59